Strategic Partnerships Gryt Health has a track record of collaborating with major pharmaceutical players (Gilead Sciences, Seagen, Bristol Myers Squibb) to support patient advocacy, real-world studies, and oncology initiatives, indicating strong VP of partnerships and potential co-marketing or sponsored patient engagement programs.

Patient Activation The company positions itself as a leader in patient activation and experience intelligence, suggesting opportunities to upsell expanded patient journey works, digital education tools, and engagement platforms for clinical trials and patient advocacy networks.

Digital Platform Expertise With a digitally enabled platform approach co-created with pharma partners and leveraging modern tools, Gryt Health can offer scalable software as a service enhancements, data collection, and patient-reported outcomes integration for trials and post-market programs.

Diversity and Equity Focus Past initiatives like Diversity in Oncology demonstrate a commitment to health equity, creating openings for partnerships around inclusive trial designs, diverse patient recruitment, and equity-focused analytics services.

Growth and Funding Signals Revenue range and a $7.5M funding profile alongside a lean team (11-50 employees) indicate efficiency and a potential for scalable solutions, making Gryt a fit for tiered engagement, pilot programs, and potential investment-led expansions.